Literature DB >> 11560971

Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results.

R S Kerbel1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11560971

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  22 in total

Review 1.  Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer.

Authors:  Seiji Yano; Yuka Matsumori; Kenji Ikuta; Hirokazu Ogino; Tamir Doljinsuren; Saburo Sone
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

2.  Antiangiogenesis cocktails - stirred or shaken?

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-10-20

3.  New chemotherapy strategies and biological agents in the treatment of childhood ependymoma.

Authors:  Karen D Wright; Amar Gajjar
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

4.  A single fusion signal for t(14;18)(q32;q21) translocation is present in both the follicular lymphoma and local endothelial cells.

Authors:  Xiaoxi Zhou; Qinlu Li; Ying Wang; Shan Huang; Lijun Jiang; Jianfeng Zhou; Yang Cao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

5.  Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.

Authors:  Steven Brem; Stuart A Grossman; Kathryn A Carson; Pamela New; Surasak Phuphanich; Jane B Alavi; Tom Mikkelsen; Joy D Fisher
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

Review 6.  Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

7.  Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.

Authors:  Ruman Rahman; Stuart Smith; Cheryl Rahman; Richard Grundy
Journal:  J Oncol       Date:  2010-04-11       Impact factor: 4.375

8.  Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats.

Authors:  Hitoshi Yoshiji; Ryuichi Noguchi; Kosuke Kaji; Yasuhide Ikenaka; Yusaku Shirai; Tadashi Namisaki; Mitsuteru Kitade; Tatsuhiro Tsujimoto; Hideto Kawaratani; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2009-11-26       Impact factor: 7.527

Review 9.  Cellular actions and signaling by endostatin.

Authors:  Ramani Ramchandran; S Ananth Karumanchi; Jun-ichi Hanai; Seth L Alper; Vikas P Sukhatme
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2002       Impact factor: 1.807

10.  Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2.

Authors:  Rebekah R White; Siqing Shan; Christopher P Rusconi; Geetha Shetty; Mark W Dewhirst; Christopher D Kontos; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.